Compiled by the ENCLAI research team following a documented methodology · Editorial oversight: Dr Natalya Mathur, Founder · Data last updated: (UTC)

Cutaneous and mucocutaneous leishmaniasis in China: 2026 cases and outbreak reports

Reported cutaneous and mucocutaneous leishmaniasis surveillance for China (CHN) — — latest record 2026-05-08

What the 2026 data shows

As of 1 March 2026, China has reported 95 cutaneous and mucocutaneous leishmaniasis cases in 2026, as published by China CDC Weekly. Our data cover only part of 2025, so no full-year 2025 figure is shown.

Of the 4 countries reporting cutaneous and mucocutaneous leishmaniasis to ENCLAI in 2026, China accounts for 2.2% of reported cases and ranks 3 by case count.

ENCLAI has logged 5 surveillance records for cutaneous and mucocutaneous leishmaniasis in China in 2026, with the most detailed reporting in Apr 2026 (2 records); the case counts run to 2026-03-01. 2 distinct surveillance sources reported this pair in 2026.

Reporting authorities for these counts: China CDC Weekly

The daily disease brief

One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.

Double opt-in — we send a confirmation link and nothing else until you click it. One-click unsubscribe on every email. See our privacy notice.

Surveillance summary

2026 cases (YTD)
95
2025 cases (full year)
incomplete year
Baseline avg (3yr)
N/A
Trend (2025)
—
2025 only partly covered

Reported cases by year, China

YearReported casesShare of worldwide reports
2023 not reported —
2024 not reported —
2025 incomplete year —
2026 (year to date) 95 2.2%

Reporting bounds and case definitions vary; historical baselines are a separate comparison measure. Worldwide share compares this country's reported figure with the sum of all countries reporting cutaneous and mucocutaneous leishmaniasis to ENCLAI for that year. "Incomplete year" means our sources cover less than ten months of that year, so no full-year figure is shown; "outbreak total to date" is a running total since an outbreak began, not a count for one year.

Surveillance records logged in 2026

MonthRecordsReporting sources
Feb 202611
Mar 202611
Apr 202622
May 202611

A record is one dated surveillance publication or one row of an official table; a month with many records is a month with detailed reporting, not necessarily more cases.

Cutaneous and mucocutaneous leishmaniasis in other countries, 2026

Country2026 casesTrend
Colombia 3,543
Ecuador 660
Lebanon 5

Other diseases reported in China, 2026

Disease2026 casesTrend
Seasonal influenza 2,235,702
Hepatitis B 328,749
Syphilis 161,768
Tuberculosis 160,195
Hand, foot and mouth disease 111,456

Questions about this page

How many cutaneous and mucocutaneous leishmaniasis cases has China reported in 2026?
As of 1 March 2026, China has reported 95 cutaneous and mucocutaneous leishmaniasis cases in 2026, as published by China CDC Weekly. Our data cover only part of 2025, so no full-year 2025 figure is shown.
Where does China publish cutaneous and mucocutaneous leishmaniasis surveillance data?
The counts on this page were published by China CDC Weekly. ENCLAI compiles and normalises them and is not affiliated with these authorities.

About this data

Figures are reported case counts as published by the originating health authorities, compiled by ENCLAI from 444 verified surveillance sources. China figures reflect the reporting available to ENCLAI; reporting periods and case definitions differ between sources, and a missing report does not establish zero cases. ENCLAI holds cutaneous and mucocutaneous leishmaniasis records for China dated from 2022. How we verify and update data: methodology & Trust Center · understanding case counts.

Track cutaneous and mucocutaneous leishmaniasis in China live — alerts, exports and sub-national drill-down: start a 7-day free trial or request a demo.

The daily disease brief

One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.

Double opt-in — we send a confirmation link and nothing else until you click it. One-click unsubscribe on every email. See our privacy notice.